Human brain aminopeptidase A: Biochemical properties and distribution in brain nuclei

Journal of Neurochemistry

Volumn 106, Issue 1, 2008, Pages 416-428

  De Mota, Nadia ^a,b,c   Iturrioz, Xavier ^a,b,c   Claperon, Cedric ^a,b,c   Bodineau, Laurence ^a,b,c   Fassot, Celine ^a,b,c   Roques, Bernard Pierre ^a,d   Palkovits, Miklos ^e   Llorens Cortes, Catherine ^a,b,c  

^a INSERM   (France)

^b Centre de Recherche Interdisciplinaire en Biologie   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Aminopeptidase A inhibitor; Human brain; Renin angiotensin system; Zinc metallopeptidases

Indexed keywords

3 AMINO 4 MERCAPTO BUTYL SULFONIC ACID; GLUTAMINE DERIVATIVE; GLUTAMYL AMINOPEPTIDASE; SULFONIC ACID DERIVATIVE;

AMBIGUUS NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN NUCLEUS; BRAIN REGION; CAPILLARY; CELL DENSITY; CHEMICAL ANALYSIS; CHOROID PLEXUS; CONTROLLED STUDY; CUNEATE NUCLEUS; ENZYME ACTIVITY; ENZYME KINETICS; HYPERTENSION; HYPOGLOSSAL NUCLEUS; HYPOTHALAMUS; IMMUNOREACTIVITY; INFERIOR OLIVE; MALE; MEDULLA OBLONGATA; MOLECULAR WEIGHT; MOUSE; NERVE FIBER; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PERIKARYON; PINEAL BODY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEPTUM PELLUCIDUM; SOLITARY TRACT NUCLEUS; SUPRAOPTIC NUCLEUS; THALAMUS MIDLINE NUCLEUS; VAGUS NERVE NUCLEUS;

ADULT; AGED; ANGIOTENSINS; ANIMALS; AUTONOMIC PATHWAYS; BLOOD PRESSURE; BRAIN; ENZYME ACTIVATION; ENZYME INHIBITORS; EVOLUTION, MOLECULAR; FEMALE; GLUTAMYL AMINOPEPTIDASE; HUMANS; HYPERTENSION; MALE; MICE; MICROCIRCULATION; MIDDLE AGED; NEUROCHEMISTRY; NEURONS; SPECIES SPECIFICITY;

RATTUS;

EID: 45249091706     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2008.05402.x     Document Type: Article

References (68)

1. Allen A. M., Chai S. Y., Clevers J., McKinley M. J., Paxinos G. Mendelsohn F. A. (1988) Localization and characterization of angiotensin II receptor binding and angiotensin converting enzyme in the human medulla oblongata. J. Comp. Neurol. 269, 249 264.
2. Allen A. M., Paxinos G., McKinley M. J., Chai S. Y. Mendelsohn F. A. (1991) Localization and characterization of angiotensin II receptor binding sites in the human basal ganglia, thalamus, midbrain pons, and cerebellum. J. Comp. Neurol. 312, 291 298.
3. Allen A. M., MacGregor D. P., Chai S. Y., Donnan G. A., Kaczmarczyk S., Richardson K., Kalnins R., Ireton J. Mendelsohn F. A. (1992) Angiotensin II receptor binding associated with nigrostriatal dopaminergic neurons in human basal ganglia. Ann. Neurol. 32, 339 344.
4. Allen A. M., Moeller I., Jenkins T. A., Zhuo J., Aldred G. P., Chai S. Y. Mendelsohn F. A. (1998) Angiotensin receptors in the nervous system. Brain Res. Bull. 47, 17 28.
5. Allen A. M., MacGregor D. P., McKinley M. J. Mendelsohn F. A. (1999) Angiotensin II receptors in the human brain. Regul. Pept. 79, 1 7.
6. Baltatu O., Nishimura H., Hoffmann S., Stoltenburg G., Haulica I. D., Lippoldt A., Ganten D. Urata H. (1997) High levels of human chymase expression in the pineal and pituitary glands. Brain Res. 752, 269 278.
7. Baltatu O., Lippoldt A., Hansson A., Ganten D. Bader M. (1998) Local renin-angiotensin system in the pineal gland. Brain Res. Mol. Brain Res. 54, 237 242.
8. Baltatu O., Cayla C., Iliescu R., Andreev D., Jordan C. Bader M. (2002) Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse ren-2 gene. J. Am. Soc. Nephrol. 13, 2681 2687.
9. Bodineau L., Frugière A., Marc Y., Inguimbert N., Fassot C., Balavoine F., Roques B. Llorens-Cortes C. (2008) Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Hypertension 51, 1318 1325.
10. Carrera M. P., Ramirez-Exposito M. J., Valenzuela M. T., Duenas B., Garcia M. J., Mayas M. D. Martinez-Martos J. M. (2006) Renin-angiotensin system-regulating aminopeptidase activities are modified in the pineal gland of rats with breast cancer induced by N-methyl-nitrosourea. Cancer Invest. 24, 149 153.
11. Chai S. Y., Mendelsohn F. A. Paxinos G. (1987) Angiotensin converting enzyme in rat brain visualized by quantitative in vitro autoradiography. Neuroscience 20, 615 627.
12. Chai S. Y., McKenzie J. S., McKinley M. J. Mendelsohn F. A. (1990) Angiotensin converting enzyme in the human basal forebrain and midbrain visualized by in vitro autoradiography. J. Comp. Neurol. 291, 179 194.
13. Chauvel E. N., Coric P., Llorens-Cortes C., Wilk S., Roques B. P. Fournie-Zaluski M. C. (1994a) Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors. J. Med. Chem. 37, 1339 1346.
14. Chauvel E. N., Llorens-Cortès C., Coric P., Wilk S., Roques B. Fournié-Zaluski M. C. (1994b) Differential inhibition of aminopeptidase A and aminopeptidase N by new β-amino thiols. J. Med. Chem. 37, 2950 2956.
15. Danielsen E. M., Noren O., Sjostrom H., Ingram J. Kenny A. J. (1980) Proteins of the kidney microvillar membrane. Aspartate aminopeptidase: purification by immunoadsorbent chromatography and properties of the detergent- and proteinase-solubilized forms. Biochem. J. 189, 591 603.
16. Feracci H., Benajiba A., Gorvel J. P., Doumeng C. Maroux S. (1981) Enzymatic and immunological properties of the protease form of aminopeptidase N and A from pig and rabbit intestinal brush border. Biochim. Biophys. Acta 658, 148 157.
17. Fournie-Zaluski M. C., Coric P., Turcaud S., Bruetschy L., Lucas E., Noble F. Roques B. P. (1992) Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation. J. Med. Chem. 35, 1259 1266.
18. Fournie-Zaluski M. C., Fassot C., Valentin B., Djordjijevic D., Reaux-Le Goazigo A., Corvol P., Roques B. P. Llorens-Cortes C. (2004) Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc. Natl Acad. Sci. USA 101, 7775 7780.
19. Glenner G. G., Mc M. P. Folk J. E. (1962) A mammalian peptidase specific for the hydrolysis of N-terminal alpha-L-glutamyl and aspartyl residues. Nature 194, 867.
20. Goto Y., Hattori A., Ishii Y., Mizutani S. Tsujimoto M. (2006) Enzymatic properties of human aminopeptidase A. Regulation of its enzymatic activity by calcium and angiotensin IV. J. Biol. Chem. 281, 23503 23513.
21. Healy D. P. Wilk S. (1993) Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II. Brain Res. 606, 295 303.
22. Herzig C. M., Schoeppe W. Scherberich J. E. (1992) Angiotensinase A (aminopeptidase A): properties of chromatographically purified isoforms from human kidney. J. Chromatogr. 625, 73 82.
23. 2+, contributes to the substrate specificity of aminopeptidase A. Biochemistry 39, 3061 3068.
24. Iturrioz X., Rozenfeld R., Michaud A., Corvol P. Llorens-Cortes C. (2001) Study of asparagine 353 in aminopeptidase A: characterization of a novel motif (GXMEN) implicated in exopeptidase specificity of monozinc aminopeptidases. Biochemistry 40, 14440 14448.
25. Kiss J. Z., Williams T. H. Palkovits M. (1984) Distribution and projections of cholecystokinin-immunoreactive neurons in the hypothalamic paraventricular nucleus of rat. J. Comp. Neurol. 227, 173 181.
26. Lalu K., Lampelo S., Nummelin-Kortelainen M. Vanha-Perttula T. (1984) Purification and partial characterization of aminopeptidase A from the serum of pregnant and non-pregnant women. Biochim. Biophys. Acta 789, 324 333.
27. Lalu K., Lampelo S. Vanha-Perttula T. (1986) Characterization of three aminopeptidases purified from maternal serum. Biochim. Biophys. Acta 873, 190 197.
28. Lee H. J., Tomioka M., Takaki Y., Masumoto H. Saido T. C. (2000) Molecular cloning and expression of aminopeptidase A isoforms from rat hippocampus. Biochim. Biophys. Acta 1493, 273 278.
29. Lejczak B., Kafarski P. Zygmunt J. (1989) Inhibition of aminopeptidases by aminophosphonates. Biochemistry 28, 3549 3555.
30. Lejczak B., De Choszczak M. P. Kafarski P. (1993) Inhibition of aminopeptidases by phosphonic acid and phosphinic acid analogues of aspartic and glutamic acids. J. Enzyme Inhib. 7, 97 103.
31. Lenkei Z., Corvol P. Llorens-Cortes C. (1995) Comparative expression of vasopressin and angiotensin type-1 receptor mRNA in rat hypothalamic nuclei: a double in situ hybridization study. Brain Res. Mol. Brain Res. 34, 135 142.
32. Lenkei Z., Palkovits M., Corvol P. Llorens-Cortes C. (1997) Expression of angiotensin type-1 (AT1) and type-2 (AT2) receptor mRNAs in the adult rat brain: a functional neuroanatomical review. Front. Neuroendocrinol. 18, 383 439.
33. Lind R. W. Ganten D. (1990) Angiotensin, Vol. 9, pp. 165 286. Elsevier, Amsterdam.
34. Lojda Z. Gossrau R. (1980) Study on aminopeptidase A. Histochemistry 67, 267 290.
35. Lowry O. H., Rosebrough N. J., Farr A. L. Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 275.
36. MacGregor D. P., Murone C., Song K., Allen A. M., Paxinos G. Mendelsohn F. A. (1995) Angiotensin II receptor subtypes in the human central nervous system. Brain Res. 675, 231 240.
37. Maktabi M. A., Heistad D. D. Faraci F. M. (1990) Effects of angiotensin II on blood flow to choroid plexus. Am. J. Physiol. 258, H414 H418.
38. Maktabi M. A., Stachovic G. C. Faraci F. M. (1993) Angiotensin II decreases the rate of production of cerebrospinal fluid. Brain Res. 606, 44 49.
39. Mendelsohn F. A., Jenkins T. A. Berkovic S. F. (1993) Effects of angiotensin II on dopamine and serotonin turnover in the striatum of conscious rats. Brain Res. 613, 221 229.
40. Migaud M., Durieux C., Viereck J., Soroca-Lucas E., Fournie-Zaluski M. C. Roques B. P. (1996) The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase A. Peptides 17, 601 607.
41. Mizuno K., Hashimoto S., Ojima M., Kunii N., Tani M., Niimura S., Watari H. Fukuchi S. (1985) Immunoreactive renin in human brain: distribution and properties. Jpn. Circ. J. 49, 1005 1011.
42. Nagatsu I., Nagatsu T., Yamamoto T., Glenner G. G. Mehl J. W. (1970) Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim. Biophys. Acta 198, 255 270.
43. Nanus D. M., Engelstein D., Gastl G. A., Gluck L., Vidal M. J., Morrison M., Finstad C. L., Bander N. H. Albino A. P. (1993) Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc. Natl Acad. Sci. USA 90, 7069 7073.
44. Ondetti M. A., Rubin B. Cushman D. W. (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196, 441 444.
45. Palkovits M. (1973) Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59, 449 450.
46. Phillips M. I. (1987) Functions of angiotensin in the central nervous system. Annu. Rev. Physiol. 49, 413 435.
47. Reaux A., Fournie-Zaluski M. C., David C., Zini S., Roques B. P., Corvol P. Llorens-Cortes C. (1999a) Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc. Natl Acad. Sci. USA 96, 13415 13420.
48. Reaux A., de Mota N., Zini S., Cadel S., Fournie-Zaluski M. C., Roques B. P., Corvol P. Llorens-Cortes C. (1999b) PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. Neuroendocrinology 69, 370 376.
49. Rozenfeld R., Iturrioz X., Maigret B. Llorens-Cortes C. (2002) Contribution of molecular modeling and site-directed mutagenesis to the identification of two structural residues, Arg-220 and Asp-227, in aminopeptidase A. J. Biol. Chem. 277, 29242 29252.
50. Rozenfeld R., Iturrioz X., Okada M., Maigret B. Llorens-Cortes C. (2003) Contribution of molecular modeling and site-directed mutagenesis to the identification of a new residue, glutamate 215, involved in the exopeptidase specificity of aminopeptidase A. Biochemistry 42, 14785 14793.
51. Rozenfeld R., Muller L., El Messari S. Llorens-Cortes C. (2004) The C-terminal domain of aminopeptidase A is an intramolecular chaperone required for the correct folding, cell surface expression, and activity of this monozinc aminopeptidase. J. Biol. Chem. 279, 43285 43295.
52. Saavedra J. M. (1992) Brain and pituitary angiotensin. Endocr. Rev. 13, 329 380.
53. Schalk C., d'Orchymont H., Jauch M. F. Tarnus C. (1994) 3-Amino-2-tetralone derivatives: novel potent and selective inhibitors of aminopeptidase-M (EC 3.4.11.2). Arch. Biochem. Biophys. 311, 42 46.
54. Simonnet G. Giorguieff-Chesselet M. F. (1979) Stimulating effect of angiotensin II on the spontaneous release of newly synthesized [3H]dopamine in rat striatal slices. Neurosci. Lett. 15, 153 158.
55. Simonnet G., Giorguieff-Chesselet M. F., Carayon A., Bioulac B., Cesselin F., Glowinski J. Vincent J. D. (1981) Angiotensin II and nigostriatal system (author's transl). J. Physiol. (Paris) 77, 71 79.
56. Song K., Allen A. M., Paxinos G. Mendelsohn F. A. (1992) Mapping of angiotensin II receptor subtype heterogeneity in rat brain. J. Comp. Neurol. 316, 467 484.
57. Stragier B., Sarre S., Vanderheyden P., Vauquelin G., Fournie-Zaluski M. C., Ebinger G. Michotte Y. (2004) Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. J. Neurochem. 90, 1251 1257.
58. Tieku S. Hooper N. M. (1992) Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem. Pharmacol. 44, 1725 1730.
59. Vazeux G., Wang J., Corvol P. Llorens-Cortes C. (1996) Identification of glutamate residues essential for catalytic activity and zinc coordination in aminopeptidase A. J. Biol. Chem. 271, 9069 9074.
60. Vazeux G., Iturrioz X., Corvol P. Llorens-Cortes C. (1997) A tyrosine residue essential for catalytic activity in aminopeptidase A. Biochem. J. 327, 883 889.
61. Vazeux G., Iturrioz X., Corvol P. Llorens-Cortes C. (1998) A glutamate residue contributes to the exopeptidase specificity in aminopeptidase A. Biochem. J. 334, 407 413.
62. Vogh B. P. Godman D. R. (1989) Effects of inhibition of angiotensin converting enzyme and carbonic anhydrase on fluid production by ciliary process, choroid plexus, and pancreas. J. Ocul. Pharmacol. 5, 303 311.
63. Wilk S. Healy D. (1993) Glutamyl aminopeptidase (aminopeptidase A), the BP1/6C3 antigen. Adv. Neroimmunol. 3, 195 207.
64. Wright J. W. Harding J. W. (1997) Important role for angiotensin III and IV in the brain renin-angiotensin system. Brain Res. Brain Res. Rev. 25, 96 124.
65. Yamada R., Mizutani S., Kurauchi O., Okano K., Imaizumi H., Narita O. Tomoda Y. (1988) Purification and characterization of human placental aminopeptidase A. Enzyme 40, 223 230.
66. Zini S., Fournie-Zaluski M. C., Chauvel E., Roques B. P., Corvol P. Llorens-Cortes C. (1996) Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl Acad. Sci. USA 93, 11968 11973.
67. Zini S., Masdehors P., Lenkei Z., Fournie-Zaluski M. C., Roques B. P., Corvol P. Llorens-Cortes C. (1997) Aminopeptidase A: distribution in rat brain nuclei and increased activity in spontaneously hypertensive rats. Neuroscience 78, 1187 1193.
68. Zini S., Demassey Y., Fournie-Zaluski M. C., Bischoff L., Corvol P., Llorens-Cortes C. Sanderson P. (1998) Inhibition of vasopressinergic neurons by central injection of a specific aminopeptidase A inhibitor. Neuroreport 9, 825 828.